Alambic Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Alambic Investment Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-69,074	Closed	-$867K	–	488
2017 Q4	$867K	Sell	69,074 -29,134	-30%	-$381K	0.1%	264
2017 Q3	$1.3M	Buy	98,208 +23,761	+32%	+$327K	0.14%	222
2017 Q2	$1.18M	Sell	74,447 -2,269	-3%	-$33K	0.14%	237
2017 Q1	$1.1M	Buy	76,716 +4,299	+6%	+$58.8K	0.14%	244
2016 Q4	$927K	Buy	72,417 +3,821	+6%	+$48.3K	0.16%	208
2016 Q3	$912K	Buy	68,596 +23,283	+51%	+$272K	0.21%	172
2016 Q2	$496K	Buy	45,313 +22,030	+95%	+$215K	0.12%	282
2016 Q1	$213K	Buy	+23,283	New	+$192K	0.07%	390

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Alambic Investment Management's IRWD Position: Q1 2018 in Review

Alambic Investment Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2018, closing a stake of 69,074 shares — an estimated $867K sold.

Alambic Investment Management first reported a position in IRWD in Q1 2016 and held it in 8 quarters. The position peaked at $1.3M in Q3 2017. 149 funds tracked by Wall St. Rank hold IRWD as of Q1 2018.

Alambic Investment Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Alambic Investment Management sold 69,074 Ironwood Pharmaceuticals shares in Q1 2018, an estimated $867K.
Alambic Investment Management first reported a position in Ironwood Pharmaceuticals in Q1 2016 and held it in 8 quarters.
Alambic Investment Management's Ironwood Pharmaceuticals position peaked at $1.3M in Q3 2017.
149 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2018.

Based on Alambic Investment Management's 13F filing for Q1 2018, filed 8 May 2018.